Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction

Journal of the American Veterinary Medical Association

Volumn 218, Issue 12, 2001, Pages 1961-1965

  Henrikson, Sarah L ^a   Rush, Bonnie R ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SALMETEROL XINAFOATE;

AEROSOL; AIRWAY OBSTRUCTION; ARTICLE; BREATHING RATE; BRONCHODILATATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HORSE; LONG TERM CARE; LUNG RESISTANCE; NONHUMAN; THORAX PRESSURE;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0035877036     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2001.218.1961     Document Type: Article

References (24)

1. 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers. Can Vet J 1904;35: 170-173.
2. Derksen F, Robinson N, Berney C. Aerosol pirhuterol: bronchodilator activity and side effects in ponies with recurrent airway obstruction (heaves). Equine Vet 1992;24:107-112.
3. Derksen FJ, Olszewski MA, Robinson NH. Use of a handheld, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with heaves. Equine Vet J 1996;28:306-310.
4. Derksen FJ, Olszewski MA, Robinson NE, et al. Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction. Am J Vet Res 1999;60:689-693.
5. Rush BR, Hoskinson JF, Davis EG, et al. Pulmonary distribution of aerosolized technetium Tc 99m pentetate after a single dose of aerosolized sulfate in horses with recurrent airway obstruction. Am J Vet Res 1999;60:764-769.
6. Ullman A, Svedmyr N. Salmeterol, a new long acting inhaled β-2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988;43:674-68.
7. Derom E, Pauwels R. Van der Straeten M. The effects of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. J Allergy Clin Immunol 1992;89:811-815.
8. Farmer P, Pugin J. β-Adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IκB/NF-κB pathway. Am J Physiol Lung Cell Mol Physiol 2000;279;675-682.
9. Buchwald A, Hochhaus G. Pharmacokinetic and pharmaco-dynamic aspects of salmeterol therapy. Int J Clin Pharmacol Ther 1998;36:642-660.
10. Pearlman D, Chervinsky P, LaForce C et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Eng J Med 1992;327:1420-1425.
11. Peters JI, Shclledy D, Jones A, et al. A randomized, placebo-controlled study to evaluate the role of salmeterol in the in-hospital management of asthma. Chest 2000;118:313-320.
12. Hoffman A. Inhaled medications and bronchodilator use in the horse. Vet Clin North Am Equine Pract 1997;13:519-530.
13. Tesarowski DB, Viel L, McDonell WN. Pulmonary function measurements during repeated environmental challenge of horses with recurrent airway obstruction (heaves). Am J Vet Res 1996;57: 1214-1219.
14. Robinson N, Olszewski M, Boehler D, et al. Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine Vet J 2000;32:393-400.
15. Rush BR, Raub ES, Rhoads WS, et al. Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res 1998;1039-1043.
16. Linden A, Rabe K, Lofdahl CG. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting β-2 adrenoceptor agonists. Lung 1996;174:1-22.
17. Votion D, Vandenput S, Duvivier D, et al. Scintigraphical evaluation of alveolar clearance in horses. Vet J 1998;156:51-58.
18. Votion DM, Vandenput SN, Duvivier D, et al. Alveolar clearance in horses with chronic obstructive pulmonary disease. Am J Vet Res 1999;60:495-500.
19. Manchee G, Barrow A, Kulkarni S, et al. Disposition of salmeterol xinafoate in laboratory animals and humans. Drug Metab Dispos 1993;21:1022-1028.
20. Sauer M, Dave M, Lake B, et al. β-2-Agonist abuse in food producing animals: use of in vitro liver preparations to assess bio-transformation and potential target residues for surveillance. Xenobiotica 1999;29:483-497.
21. McKenzie HC, Murray MJ. Concentrations of gentamicin in serum and bronchial lavage fluid after intravenous and aerosol administration of gentamicin to horses. Am J Vet Res 2000;61: 1185-1190.
22. Korosec M, Novak R, Myers E. Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthma. Am J Med 1999;107:209-213.
23. Inman M, O'Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med 1996;153:65-69.
24. Newnham D, Ingram C, Earnshaw J, et al. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma. Respir Med 1993;87:439-444.